Endothelin receptor selectivity in chronic kidney disease: rationale and review of recent evidence. - Wikidata - awgldk - TriplyDB

Endothelin receptor selectivity in chronic kidney disease: rationale and review of recent evidence.

Endothelin receptor selectivity in chronic kidney disease: rationale and review of recent evidence.

http://www.wikidata.org/entity/Q37428041

about

Endothelin receptors and their antagonists Improvements in the Management of Diabetic Nephropathy Kidney dysfunction in patients with pulmonary arterial hypertension Endothelin, hypertension and chronic kidney disease: new insights.Emerging drugs for chronic kidney disease.Addition of atrasentan to renin-angiotensin system blockade reduces albuminuria in diabetic nephropathy.Relationship of urinary endothelin-1 with estimated glomerular filtration rate in autosomal dominant polycystic kidney disease: a pilot cross-sectional analysis.Endothelin ETA receptor/lipid peroxides/COX-2/TGF-β1 signalling underlies aggravated nephrotoxicity caused by cyclosporine plus indomethacin in rats ET-1 actions in the kidney: evidence for sex differences.Endothelin antagonists for diabetic and non-diabetic chronic kidney disease.Direct action of endothelin-1 on podocytes promotes diabetic glomerulosclerosis Cellular and molecular mechanisms of diabetic glomerulopathy.The effect of antihypertensive drugs on chronic kidney disease: a comprehensive review.Novel effective drugs for diabetic kidney disease? or not?A perspective on chronic kidney disease progression.Endothelin-receptor antagonists for diabetic nephropathy: A meta-analysis.

P2860

Q27023208-E954C5F6-94B6-43CD-A685-6872F107F611 Q28080717-2DF2401A-BB61-4437-A5B3-DB0986E95FEF Q33738621-037E2FD2-4767-4741-B726-9AB70F91FBB3 Q34028803-961F7A17-4391-47B5-8149-17691CBB81A5 Q34420383-A84C9892-042C-42EE-854A-B741CAC4E8EF Q34726905-C05030F7-4969-4708-8D33-68AB6F6C2DBA Q35938697-6B2C811D-74DE-4CA6-990D-D5DF0AB97D57 Q36016411-95E54B08-927A-4483-8406-0DC1D212200F Q36610325-DE377E19-30E2-4676-9319-DA6D44F80DA1 Q37219055-E73AED20-3455-4C76-9781-F6A3A3782AA6 Q37733555-5EB8EDC8-FD9E-4321-BDA2-6CA869166351 Q38010045-86DABFA7-00DC-4BC8-896A-E63B70B33EC0 Q38050872-42129EF7-DFDC-49FC-AC6C-BDB57CE5C992 Q38265818-0BD97B5D-2C3F-474E-BCF5-5AD98E8C9CD9 Q39038570-3BE99079-C35D-42D9-AEF5-6F871697835D Q51000648-ADB5EE71-8265-4F52-BD82-417EB13B9E28

P2860

Endothelin receptor selectivity in chronic kidney disease: rationale and review of recent evidence.

http://www.wikidata.org/entity/Q37428041

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on June 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Endothelin receptor selectivit ...... and review of recent evidence.

@en

Endothelin receptor selectivit ...... and review of recent evidence.

@nl

type

label

Endothelin receptor selectivit ...... and review of recent evidence.

@en

Endothelin receptor selectivit ...... and review of recent evidence.

@nl

prefLabel

Endothelin receptor selectivit ...... and review of recent evidence.

@en

Endothelin receptor selectivit ...... and review of recent evidence.

@nl

P1433

Q37428041-0ABE25ED-D86C-40B9-B375-D4358A5090A2

P1476

Q37428041-B9AB8511-8FDB-4759-939E-E2C07135ACB1

P2093

Q37428041-2980C37B-A67C-4612-AFF4-0D94CFE4D33D

Q37428041-3E7D9A85-2EEC-40FB-8017-8C4CACBA0762

P2860

Q37428041-07D3989E-B9B8-406C-8F40-657C1F4BF696

Q37428041-26AF75F4-D9B9-4C05-9126-A8D8A0421C60

Q37428041-2C52F65B-37D5-47E2-A3D4-7AD333DA389A

Q37428041-5DC851D5-96B8-457D-B1A4-FCD25DFDA33F

Q37428041-6DDF2770-B0B4-4D7A-8C68-754160A0835F

Q37428041-7BCDAD9A-8825-47A9-862F-044B4BB0B5B5

Q37428041-91CF06BD-1554-49B7-A5B0-350A87DF6D6E

Q37428041-97AFE53F-68E4-4408-93C8-4D2329471F95

Q37428041-C1B324B6-942C-4FF7-9A29-BA8919328C51

P304

Q37428041-D2B01B5D-D3AF-4FA8-9577-3095FB7463F2

P31

Q37428041-209E0463-ED9F-4F43-8827-041BD1A8686B

P356

Q37428041-282B2D4C-E82F-4E83-8A33-F2DE6D83E9B9

P478

Q37428041-E9B251E1-539F-425F-8D75-5069085A3912

P577

Q37428041-6316E4A9-0DD8-4D06-AA4E-3E4BE871A063

P698

Q37428041-BDFCA2CE-D23E-49A6-B2D6-77083B81D2A4

P356

J.1365-2362.2009.02121.X

P1433

European Journal of Clinical Investigation

P1476

Endothelin receptor selectivit ...... and review of recent evidence.

@en

P2093

D Pittrow

http://www.w3.org/2001/XMLSchema#string

W Neuhofer

http://www.w3.org/2001/XMLSchema#string

P2860

Collecting duct-specific knockout of endothelin-1 causes hypertension and sodium retention

In response to protein load podocytes reorganize cytoskeleton and modulate endothelin-1 gene: implication for permselective dysfunction of chronic nephropathies

Induction of endothelin-1 gene by angiotensin and vasopressin in endothelial cells.

Physiology and pathology of endothelin-1 in renal mesangium.

Activation of NF-kappaB in tubular epithelial cells of rats with intense proteinuria: role of angiotensin II and endothelin-1.

Perspectives in endothelin research: tubulointerstitial actions of endothelins in the kidney: roles in health and disease.

Haemodynamic and renal tubular effects of low doses of endothelin in anaesthetized rats.

Endothelin antagonism prevents early EGFR transactivation but not increased matrix metalloproteinase activity in diabetes.

Classification of endothelin receptors and antagonists in clinical development

P304

50-67

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1365-2362.2009.02121.X

http://www.w3.org/2001/XMLSchema#string

P478

39 Suppl 2

http://www.w3.org/2001/XMLSchema#string

P577

2009-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19335747

http://www.w3.org/2001/XMLSchema#string